Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Research and Innovation Action · Running

iCare Integrated assessment and Advanced Characterisation of Neuro-Nanotoxicity

Coordinator
International Iberian Nanotechnology Laboratory, Portugal
Runs
1 January 2023 to 31 December 2026
Status
Running
EU funding
€2.7m
Total cost
€2.7m
Partners
12 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101092971

What the project is doing

In the project's own words, from its summary on CORDIS.

The incidental, accidental, or intentional release of manufactured nanomaterials into the environment and its exposure to humans is inevitable due to the exponential growth in invention, production, and use of them. It can have a huge impact in our health specially in the most sensible and exposed human body organs such us lungs, stomach, and brain. iCare aim to to develop a resilient and adaptive set of advanced imaging technologies to quantify physical-chemistry properties for ANMC in complex matrices.

The main objective will focus on a integrated model system to characterize and predict the impact of nanomaterials on brain health to prevent the toxicity nanomaterials. The project makes accessible for industry a set of techniques and methodologies to evaluate changes in morphology, chemical composition and reactivity of nanomaterials when exposed to complex homogenous matrices mimicking environmental and biological exposure, with a particular emphasis on high-resolution imaging methodologies.

To achieve this goal the project the project brings together in the consortium 11 partners from different backgrounds such as RTOs, SMEs, industries and universities from different EU and non-eu countries and coming from different fields like nanotech, toxicology, advanced materials, advanced imaging, …During the 48 months long of the project, the consortium will work on the development of different activities to achieve the following results: 1)new imaging methods achieving new high resolution methodologies and new super resolution imaging techniques 2)development of toxicology testing protocols and addressing current gaps in nanotoxicology, 3)development of tools and methods bringing the gap in vitro and in vivo testing, 4)efficiency of materials and product development 5)Delivery of reliable data and improved data reporting and finally development of harmonised standardised test methods that can be used in regulatory frameworks.

Topics

Who is involved

OrganisationCityCountryRole
International Iberian Nanotechnology LaboratoryBragaPortugalCoordinator
The University of SydneySydneyAustraliaAssociatedpartner
Nanotechnology Industries AssociationBruxelles / BrusselBelgiumParticipant
Temas Solutions GmbHHausenSwitzerlandAssociatedpartner
Avanzare Innovacion Tecnologica SLNavarreteSpainParticipant
Fundacion GaikerZamudioSpainParticipant
Fondazione Istituto Italiano Di TecnologiaGenovaItalyParticipant
Optics11 B.v.AmsterdamNetherlandsParticipant
Optics11 Life B.V.AmsterdamNetherlandsParticipant
Instytut Chemii Bioorganicznej Polskiej Akademii NaukPoznanPolandParticipant
Advanced Material Development LtdFarnboroughUnited KingdomAssociatedpartner
Versarien plcLonghope GloucestershireUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI